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It is well known that not all animals manifesting clinical signs of street rabies virus 
(SRV) 1 infection  die.  These  observations  have  been  made  in  natural  (1-4)  and 
experimental infections (5-12). In one study, it was shown that  16% of outbred Swiss 
Webster mice inoculated intraperitoneally (i.p.)  with SRV survived after developing 
signs  of illness  and  that  recovery was  associated  with  high  levels  of rabies  virus- 
neutralizing  antibody in  the  brain  (5).  In  contrast,  Baer  and  associates  (12)  have 
shown that  little,  if any, SRV-neutralizing antibody was present  in brains of Swiss 
ICR mice  that  survived  with  sequelae  of infection  after  peripheral  inoculation  of 
SRV. The importance of virus-neutralizing antibody in brains of mice in one model 
of sickness  with recovery, but not the other, is perplexing. This difference might be 
explained  by  the  genetic  constitution  of the  host  in  that  it  has  been  shown  that 
immunized substrains of outbred Swiss  mice vary in their resistance  to rabies  virus 
(13,  14). Furthermore,  greater  vaccine protection has been  obtained  in  Swiss  than 
non-Swiss mice (15). 
To more adequately define parameters responsible for resistance/susceptibility to 
SRV  infection,  and  for  recovery from  infection  after  onset  of clinical  signs,  it  is 
important  to  study a  host  in  which  all  members behave  identically.  Thus,  several 
t 
inbred mouse strains were tested in the anticipation that strains would be identified 
that responded differently to SRV. It is shown that there was a  marked variation in 
strain  susceptibility  to  i.p.  inoculated  SRV  and  that  resistance  was  genetically 
controlled.  Furthermore,  clinical  signs  were  apparent  only occasionally in  mice  of 
some resistant strains. Mice of other resistant strains developed these signs, but disease 
failed to progress and they survived. 
Materials and Methods 
Mice.  SJL/J, CBA/J, DBA/2J, A/J, B10.ASgSnJ, C57BL/6J, A.SW/SnJ, and A/WySnJ 
mice were purchased  from The Jackson Laboratory, Bar Harbor, ME.  C57BL/10ScN mice 
were obtained from the National Institutes of Health, Bethesda, MD, and BALB/cAnNHaPBr 
mice were purchased  from Harlan-Sprague Dawley, Madison,  WI. All mice were maintained 
as inbred  stocks at the Rocky Mountain Laboratories  (RML).  Athymic nude mice, produced 
by successive cross-intercrossing onto a  BALB/c background,  were purchased  from  Harlan- 
Sprague Dawley and maintained as outbreds  at the RML. 
1Abbreviations used in  this paper: CNS, central nervous system; CVS, challenge virus standard; i.c., 
intracerebral; MEM-BSA, minimal essential medium-bovine  serum albumin; MICLDs0,  mouse intracere- 
bral 50% lethal dose; RML, Rocky  Mountain Laboratories; SRV, street rabies virus; SW, Swiss-Webster. 
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F1 hybrids and backcross mice were produced in our laboratory. All mice used were 8-15 wk 
of age. 21-d-old outbred Swiss-Webster  (SW) mice raised at the RML were used to prepare and 
to titrate stock viral pools and individual brain suspensions for virus. 
Rabies  Viruses.  Unless stated otherwise,  mice were  inoculated with a wild-type SRV that 
had  been  isolated  from  an  adult  bat  (Eptesicus fuscus)  and  then  passaged  six  times  by 
intracerebral  (i.c.) inoculation in  SW  mice.  The  brain  suspension titer  was  106.5 mouse 
intracerebral 50% lethal doses (MICLDs0)/0.03 ml as calculated by the method of Reed and 
Muench (16). SRV that had been isolated from cat, dog,  sheep,  skunk, or another bat were 
kindly provided by Ms. Bernie Kraft, Montana Veterinary Diagnostic Laboratory, Bozeman, 
MT. These viruses  had been passaged two to  three times i.c.  in SW mice, and their brain 
suspension  titers ranged from 106.o to 106.9 MICLDso/0.03 ml. The laboratory-adapted challenge 
virus standard (CVS)  rabies virus was  obtained from John Moore of the  RML.  The brain 
suspension titer was  106.5 MICLDso/0.03 ml. 
All stock viral pools were prepared as 10% mouse brain suspensions and stored at -70°C in 
minimal essential medium (Flow  Laboratories, McLean, VA)  containing 2%  bovine serum 
albumin (Miles  Laboratories, Elkhart, IN),  100 U  of penicillin G  (Eli Lilly and Co.,  Indian- 
apolis, IN) per ml and 1/~g of amphotericin B (E. R. Squibb and Sons, Inc., Princeton, N  J) per 
ml (MEM-BSA). Virus titrations were done by i.c. inoculation of 0.03 ml of serial 10-fold viral 
dilutions in MEM-BSA into six SW mice per dilution. 
Experimental Design.  In most instances, mice were inoculated i.p. with 0.5 ml of 10% mouse 
brain suspension containing 5 ×  10  7 MICLDso of SRV. Mice were held in glass jars in which 
watering bottle stems were less than 0.5 inch from the bedding surface.  The close proximity of 
water to the bedding allowed paralyzed mice to drink, preventing deaths due to dehydration. 
Each day mice were  observed for deaths and clinical signs of illness such as ruffled fur and 
spasticity and/or paralysis of the legs. 21 d after inoculation, survivors were killed and serum, 
brain, and cerebrospinal fluid were  harvested and stored at -70°C. Animals that died were 
considered susceptible. Animals that  survived were considered resistant, and those resistant 
mice that survived after onset of clinical signs were judged to have recovered from disease. 
Statistical Analysis.  Analysis of statistical significance of data was performed by the X  2 test 
for a 2 ×  2 contingency table. 
Results 
Resistance of Inbred Mouse Strains to SRV.  10 inbred strains of mice were inoculated 
i.p. with 5 ×  l0  T MICLDs0 of virus. The data presented in Table I show that female 
SJL, CBA, BALB/c, and DBA/2 mice were highly resistant to clinical disease (590% 
survivors). A  similar resistance also was noted in male SJL and CBA, but was not as 
apparent in male BALB/c and DBA/2 mice. The males in the latter two strains were, 
however,  greater than nine times more resistant than male mice of the susceptible 
strains (see below). 
In contrast to  these strains, male and female A.SW/Sn and A/WySn mice were 
highly susceptible to  i.p.  inoculated virus  (_--<8% survivors, Table I).  C57BL/10,  A, 
B 10.ASgSn, C57BL/6, and outbred athymic nude mice were of moderate and variable 
susceptibilities. Female mice of two substrains, A and A/WySn, differed substantially 
in  their  susceptibility to  clinical disease  (41%  vs.  3%  resistant,  respectively),  and 
athymic nudes were somewhat more resistant than highly susceptible A.SW/Sn and 
A/WySn mice (Table I). Additional experiments have shown that 1.7 ×  106 MICLDs0 
of i.p. inoculated SRV failed to kill any of the inbred mice, indicating that a threshold 
of resistance was present in all strains. The extent of this marked resistance in SJL 
and CBA mice was substantiated by their  100%  resistance to >1  ×  10  s MICLD~o of 
virus  (data  not shown). These  data  also  indicated that  resistance to  SRV  was  not 
controlled  solely  by  the  major  histocompatibility locus  (H-2)  because  susceptible 
A.SW/Sn and resistant SJL mice have the same H-2  s haplotype. DONALD L.  LODMELL 
TABLE  I 
Resistance of Inbred Mouse Strains to SR V* 
Strain  H-2 
Survivors/total (%) 
Female  Male 
SJL/J  s  74/74 (100) 
CBA/J  k  56/56 (100) 
BALB/cAnN  d  51/52 (98) 
DBA/2J  d  36/40 (90) 
C57BL/10ScN  b  46/93 (50) 
A/J  a  9/22 (41) 
B  10.A/SgSnJ  a  13/35 (37) 
C57BL/6J  b  18/66 (27) 
A.SW/SnJ  s  3/37 (8) 
A/WySnJ  a  2/62 (3) 
Athymic on BALB/cAnN  d  4/21 (19) 
background 
62/62 (100) 
32/34 (94) 
29/50 (58) 
5/9  (56) 
7/42 (17) 
ND~ 
8/16 (50) 
3/19 (16) 
2/35 (6) 
1/51 (2) 
2/19 (11) 
* 8- to 15-wk-old  mice  were inoculated i.p. with 5 X 
d postinoculation, the experiment was terminated. 
:~ Not done. 
107 MICLDso of SRV. 21 
TABLE  II 
Susceptibility of Inbred Strains of Mice to i.c. Inoculation of SRV* 
Mouse strain 
Concentration of virus 
(MICLD~o) 
1,000  100  10 
suwivo~/to~l 
SJL  0/5  0/5  0/5 
CBA  0/5  0/5  0/5 
A/WySn  0/5  0/5  0/5 
A.SW/Sn  0/5  0/5  0/5 
* 12-wk-old female mice were inoculated i.c. with various concentrations of 
SRV. All mice were dead 14 d after inoculation. 
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Susceptibility of  Inbred Strains of  Mice to Intracerebral Inoculation  of SR V.  The experiments 
described above have shown that strains of mice varied markedly in their susceptibility 
to i.p. inoculated SRV. This observation raised the question of whether similar results 
would be obtained if virus were inoculated directly into the target organ. The results 
presented in Table II show that  1,000,  100,  or  10  LD~0 of i.c.  inoculated virus was 
lethal for all mice tested. It also was determined that i.e. inoculated virus replicated 
equally well in brains of mice that  differed in their susceptibility to i.p.  inoculated 
virus (Table III). Thus, genetic control of resistance to rabies virus was not apparent 
when virus was inoculated i.c. 
Resistance of SJL and A.SW/Sn  Mice to Different  SRV Isolates.  The data in Table I 
show a marked variation in the susceptibility of inbred strains of mice to a  SRV that 
had been isolated from a bat. To determine whether these differences in susceptibility 
were unique to one virus isolate, resistant SJL and susceptible A.SW/Sn mice were 
inoculated i.p. with one of six different SRV isolates. It is shown in Table IV that all 
isolates were lethal for A.SW/Sn mice and that none killed SJL mice. Thus, variation 
in mouse strain susceptibility was not affected by the source of SRV. In contrast, i.p. 454  GENETIC CONTROL  OF  RESISTANCE TO STREET  RABIES VIRUS 
TABLE III 
Replication of SR V in Brains of SJL and A~ WySn Mice after i.c. Inoculation  * 
Mouse strain 
Hours postinoculation 
24  48  72  96  120 
MICLDso, logw/O.03 ml 
SJL  <0.7, 0.7, 0.75  0.7,  0.7, 0.7  1.4, 1.8, 2.5  3.6,  4.0, 4.2  3.5,  4.0, 4.3 
A/WySn  0.7, 0.7, 1.0  0.75,  1.0, 1.5  1.4, 1.5, 1.5  2.5,  3.8, 4.3  3.3,  4.1, 4.5 
Resistance of SJ  L 
*  12-wk-old female mice were inoculated i.c. with  1,000 LDs0 of SRV. At the indicated 
intervals, brains were removed and titrated for infectious virus by i.c. inoculation of 21-d- 
old SW mice. Values represent individual titers of three mice per strain per test interval. 
TABLE IV 
and A.SW/  Sn Mice to Various SR V lsolates * 
Virus isolated 
from  MICLDs0:~ 
Survivors/total (%) 
A.SW/Sn  SJL 
Dog  1.7 N 107  0/5 (0)  5/5 (100) 
Sheep  5.0  X  10  7  1/5 (20)  5/5 (100) 
Bat  5.0 X 107  0/5 (0)  5/5 (100) 
Cat  6.7 X 107  1/5 (20)  5/5 (100) 
Skunk  1.1 ×  10  s  0/5 (0)  5/5 (100) 
Bat  1.3 ×  l0  s  0/5 (0)  5/5 (100) 
*  8-  to 15-wk-old  female mice were inoculated i.p. with rabies viruses isolated 
from six  different animals. The  experiment was  terminated  21  d  after 
inoculation. 
:~ Concentration of virus inoculated i.p. as determined by i.c. inoculation of 
21-d-old SW mice. 
inoculation of 5 X  107 MICLDs0 of highly pathogenic laboratory-adapted CVS rabies 
virus, which has been propagated by serial i.c. passages in laboratory animals and is 
characterized  by  a  rapidly  fatal  disease  course  after  i.c.  inoculation, produced  a 
markedly different result: all SJL, CBA, A/WySn, and A.SW/Sn mice died (data not 
shown). Thus, virulence factor(s) of CVS virus overcame the genetic resistance of SJL 
and CBA mice to i.p. inoculated SRV. 
Resistance ofF1 Hybrids  and Backcross Mice to SRV.  F1 hybrids produced by crossing 
resistant strains with moderately and highly susceptible strains of mice were inoculated 
i.p. with SRV to determine the dominant phenotype. The data presented in Table V 
show that all female and most male F1 hybrids produced by 16 different crosses were 
highly  resistant  to  infection  (_-->86% survivors).  In  three  instances,  however,  male 
hybrids produced from crosses involving DBA/2 mice were _--<60% resistant, whereas 
females of these  same crosses  were  100%  resistant.  It  also  has  been shown  that  F1 
hybrids produced by crossing resistant mice (SJL  ×  CBA) were  100%  resistant, and 
crosses of susceptible mice (A/WySn ×  A.SW/Sn) were only 4% resistant (data not 
shown). These data indicate that resistance was dominant, that gene complementation 
did not influence resistance of F1 hybrids produced from susceptible strains, and that 
if a sex factor was important it was obscured in 97% (724/747) of the F1 hybrids. 
The  number of genes  controlling susceptibility was  determined  by  inoculating 
backcross mice produced by mating F1 hybrids with susceptible parents (Table VI). 
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TABLE V 
Resistance of Fz Hybrids to SRV* 
F1 Hybrid 
(female ×  male) 
Survivors/total 
Female  Male 
% 
(SJL x  A/WySn)  48/49 (98)  59/59 (100) 
(A/WySn × SJL)  18/18  (100)  42/42 (100) 
(SJL x  A.SW)  31/33 (94)  40/41  (98) 
(A.SW ×  SJL)  6/7  (86)  6/7  (86) 
(CBA x  A/WySn)  8/8  (100)  13/13  (100) 
(A/WySn X CBA)  46/47 (98)  52/57 (91) 
(CBA × A.SW)  18/19 (95)  16/18 (89) 
(A.SW X CBA)  20/20 (100)  22/24 (92) 
(A/WySn ×  DBA/2)  7/7  (100)  6/10 (60) 
(SJL ×  C57BL/6)  8/8  (100)  7/8  (88) 
(SJL X C57BL/10)  31/31  (100)  35/35 (100) 
(C57BL/10 X SJL)  43/44 (98)  33/34 (97) 
(B10.A ×  SJL)  14/14  (100)  13/13  (100) 
(B10.A × CBA)  25/29 (86)  16/17  (94) 
(B10.A ×  DBA/2)  18/18  (100)  2/8  (25) 
(DBA/2 × C57BL/6)  3/3  (100)  3/6  (50) 
* 8- to  15-wk-old F1  hybrids were inoculated i.p. with 5 ×  10  7 MICLDs0  of 
SRV.  The  experiment  was  terminated  21  d  after  inoculation.  Control 
resistant SJL and susceptible A/WySn mice were included in all experiments. 
TABLE  VI 
Resistance to SRV of Backcross Mice Produced by Mating F1 Hybrids with 
Susceptible Parents  * 
Backcross 
(female X male) 
Survivors/total 
Female  Male 
(A/WySn ×  SJL)F1 × A/WySn 
A/WySn X (A/WySn X SJL)F1 
(SJL x  A/WySn)F1 X A/WySn 
(SJL × A.SW/Sn)F1 X A.SW/Sn 
% 
74/128  (58):~  68/121  (56)~ 
24/38  (63)§  19/33  (58)§ 
53/95  (56):1:  35/83  (42)~: 
60/75  (80)11  40/64  (63)§ 
* 8- to 15-wk-old baekcross  mice were inoculated i.p. with 5 ×  107 MICLD~o 
of SRV. The experiments were terminated 21  d after inoculation. Control 
resistant  SJL and susceptible A/WySn mice were included in all experiments. 
Results  are statistically  significant  for one gene controlling susceptibility. 
§ Results  are statistically  significant  for one or two genes controlling suscepti- 
bility. 
H  Results are statistically  significant for two genes controlling susceptibility. 
susceptibility  in  both  male  and  female  progeny.  Interestingly,  the  percentage  of 
survival appeared  to be somewhat  greater  in  female than  male mice. The  ostensible 
enhanced  resistance of females in these backcrosses  may be due to a  sex-linked factor 
that  was not apparent  until the dominant  resistant  gene(s)  was diluted. 
Additional evidence that  susceptibility was  inherited  as one gene in the  (A/WySn 
X  SJL)FI ×  A/WySn  backcross  progeny was shown with F2 hybrids;  42/52  (80%)  of 
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TABLE VII 
Comparison of Clinical Responses in Mouse Strains Resistant to SR V* 
Recovered survi- 
Strain  H-2  Survivors/total  vors/total survivors 
%  % 
SJL  s  136/136 (100)  11/136 (8) 
CBA  k  86/88  (98)  21/86  (24) 
DBA/2  d  41/49  (84)  28/41  (68) 
BALB/c  d  80/102 (78)  78/80  (98) 
*  8-  to  15-wk-old male  and female mice were inoculated  i.p. with  5  ×  10  7 
MICLDs0 of SRV.  21d  postinoculation,  the experiment  was terminated. 
Mice that survived after onset of clinical symptoms were judged to have 
recovered from disease. 
shown). This segregation was consistent with the expected 75%  value for survival in 
Fz hybrids for a  one-susceptible gene model. 
Comparison of Clinical  Response in Mouse Strains Resistant to SRV.  It is shown in Table 
VII that two distinctly different clinical responses occurred in resistant mouse strains 
inoculated i.p. with SRV.  Few SJL and CBA mice developed signs of clinical illness 
such  as ruffled fur and spasticity and/or  paralysis of the legs. A  high percentage of 
DBA/2 and BALB/c mice did develop these signs, but disease failed to progress and 
they survived. The severity of paresis in the latter group also was more extensive than 
that  which  occasionally occurred  in  SoIL  and  CBA  mice.  Even  though  SRV  was 
isolated from  the spinal cord and  brain  of resistant  SJL  mice that  did not  develop 
signs  of illness, they  never  became  unconscious.  In  contrast,  susceptible  mice  that 
contained  high  levels of SRV  in  brain  and  spinal cord became unconscious  before 
death  (data not  shown).  These  data  indicate that  the sensory neurons  of mice  that 
died were affected, whereas those of the survivors were not. 
All survivors tested were resistant to  100 LDs0 of i.c. inoculated SRV, which killed 
100%  of control mice of similar age (data not shown). Thus,  even though there were 
no clinical signs of infection of the central nervous system (CNS)  in many mice, they 
had developed resistance to a  subsequent  lethal i.c. challenge of SRV. 
Discussion 
In this study of the genetic control of resistance to i.p. inoculated SRV in mice, it 
was found that  (a)  there were marked differences in resistance among inbred strains 
of mice,  (b)  female  mice  in  two  of four  resistant  strains  were  more  resistant  than 
males,  (c)  clinical signs with  either minimal  CNS  implications or marked  paralysis 
occurred in resistant strains and were strain specific, (d) resistance was dominant and 
not controlled solely by the H-2 complex,  (e)  susceptibility appeared to segregate as 
one and/or two genes, (f) the difference in strain susceptibility was not dependent on 
the SRV isolate, and (g) all strains were susceptible to i.c. inoculated SRV. 
The  evidence  for  genetic  control  of resistance was  obtained  using  inbred  mouse 
strains,  F1  and  F2  hybrids,  and  progeny  produced  by  backcrossing  F1  hybrids  to 
susceptible  parents.  It  appeared  that  susceptibility segregated  as  one  and/or  two 
genes. These results were dependent on the strain and/or sex of the susceptible parent 
used  to  produce  backcross  progeny.  In  the  two  instances  in  which  the  susceptible 
parent  was  an  A/WySn  male,  one  gene  controlled  susceptibility.  If,  however,  the DONALD L.  LODMELL  457 
susceptible parent was an A.SW or a female A/WySn, one or two genes appeared to 
control  susceptibility.  The  reason  for  this  variation  is  unknown  and  somewhat 
vexatious.  Experiments  in  progress  to  explain  these  differences,  wherein  second 
backcross progeny produced  from first backcross rabies-resistant males crossed with 
susceptible females are challenged i.p. with SRV, should confirm if one and/or two 
genes for susceptibility breed true. 
Several examples of the greater resistance of female mice to i.p. inoculated SRV as 
compared with males were detected in this study. The most obvious illustration was 
BALB/c and DBA/2 mice and F1 hybrids produced with DBA/2 mice. Also, female 
backcross  progeny  consistently  were  more  resistant  than  their  male  counterparts. 
Enhanced resistance to various viral and bacterial pathogens of female as compared 
with  male  mice  has  been  well  documented  (17-22).  It  also  has  been  shown  in 
immunized outbred Swiss mice challenged  i.c.  with rabies virus (13).  Differences in 
sex chromosomes and/or sex hormones have been suggested as possible influences in 
the enhanced  resistance of female mice (23).  The findings  presented  herein  suggest 
that  another defense mechanism, which  is masked in some strains,  exists in  female 
mice.  In  strains  such  as  SJL,  this  component  appeared  to  be  hidden  by  a  more 
dominant  factor,  but  as  dilution  occurred  with  backcrossing,  it  became apparent. 
Conversely, in BALB/c and DBA/2 mice, the dominant factor appeared to be weaker 
and consequently sex-linked differences in resistance were immediately apparent  in 
inbreds  and F1 hybrids.  Experiments in  progress, wherein  highly resistant  SJL and 
CBA mice, which show no sex difference in susceptibility, are crossed with resistant 
BALB/c and DBA/2 mice should help to elucidate this sex-linked factor. 
During  these  experiments,  two  entirely  different  clinical  responses  occurred  in 
resistant mice, depending on whether they were inbreds, Fa or F2 hybrids, or backcross 
progeny:  (a) no or only minimal clinical signs of disease and (b) obvious illness with 
paralysis. Even though many SJL mice remained asymptomatic with regard to spinal 
cord infection, i.e., they showed no leg paralysis, preliminary data have shown that 
SRV was present in their spinal cords and brains 5-7 d  after i.p. inoculation. These 
data indicate that their motor neurons were not involved in the course of infection or 
that the extent of infection was inadequate  to cause motor dysfunction. Why SRV, 
which invaded the CNS, did not cause signs of disease and why virus was not detected 
in spinal cords and brains of SJL mice ~10 d  postinoculation is unknown  (data not 
shown). It is conceivable that this is partly due to the resistance of mice that survived 
after i.p. inoculation of SRV. It is likely that resistance was not associated with SRV 
replication  in the brain in that  (a)  low concentrations of i.c.  inoculated  SRV killed 
susceptible and resistant strains (Table II) and (b) similarly inoculated virus replicated 
with equal efficiency in brains of mice of different susceptibilities  (Table III). Thus, 
physiological  (24),  virological  (25-28),  nonimmune  (29-34),  or  immune  (35-42) 
factors alone or in combination must be considered as mechanisms of resistance. At 
present, neutralizing antibody appears to be important in that preliminary data have 
indicated  that the first detectable serum-neutralizing antibody titers of mice inocu- 
lated  i.p.  with  SRV were threefold  higher  in  SJL and  CBA  than  in  A/WySn  and 
A.SW mice. These titers consistently remained 5- to  10-fold higher in resistant mice. 
Moreover,  it  recently  has  been  shown  that  mice which  produce  high  rabies  virus 
serum-neutralizing  antibody  titers  are more resistant  to rabies infection  than  mice 
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emphasized by our previous studies (5) and by investigations of  Wiktor and Koprowski 
(43) who showed that mice inoculated subcutaneously with hybridoma cells producing 
anti-rabies antibody were protected against i.c. rabies virus challenge. It also has been 
noted in this laboratory that passive i.p.  transfer of mouse anti-rabies immune serum 
protected mice against i.c. challenge with  100 ICLDs0 of SRV (data not shown). 
It has been  shown for the  first  time  that  there  is  genetic control of resistance  to 
SRV in mice.  Resistance was dominant and susceptibility appeared to segregate as 
one and/or two genes.  In some resistant strains, female mice were more resistant than 
males.  Furthermore,  resistant  strains  were  identified  that  usually  remained  either 
asymptomatic or,  in contrast,  developed signs of clinical  disease  but survived. This 
model of SRV infection in  mice provides promising probes for the  investigation of 
resistance mechanisms, male-female differences in resistance, and survival after onset 
of clinical disease. 
Summary 
Resistance  to  intraperitoneally  inoculated street  rabies  virus  (SRV)  in  mice was 
shown to be under genetic control.  SJL/J, CBA/J, DBA/2J, and BALB/cAn mice 
were resistant, whereas A/WySn/J and A.SW/SnJ mice were susceptible. In addition, 
female mice of the resistant BALB/cAn and DBA/2J strains were more resistant than 
their male counterparts. Resistance was not controlled solely by the major histocom- 
patibility  locus because  susceptible  A.SW/SnJ  and  resistant  SJL/J  mice  have  the 
same  H-2 S haplotype.  Challenge  of FI hybrids produced by crossing resistant  and 
susceptible strains indicated resistance was dominant (97% survivors). Inoculation of 
backcross mice produced by mating F1 hybrids with susceptible parents showed that 
one  and/or  two  genes  controlled  susceptibility.  Furthermore,  inoculation  of SRV 
obtained from six different animals indicated that differences in strain susceptibilities 
were not dependent on the SRV isolate.  Genetic control of resistance  to SRV was, 
however, abrogated  by intracerebral  inoculation of virus.  Resistant  strains  of mice 
were detected that either remained asymptomatic or, in contrast, developed signs of 
clinical disease,  but  disease  failed to progress and they survived. The recognition of 
resistant and susceptible strains of mice, differences in female-male resistance within 
the same resistant  strain, as well as dissimilar clinical responses in different resistant 
mouse  strains  to  intraperitoneally  inoculated  SRV  provide  promising  probes  for 
investigation  of host  resistance  and  mechanisms  for survival  after  onset  of clinical 
rabies. 
I thank Drs. Bruce Chesebro, John Portis, and Miles Cloyd for helpful discussions, Rod Parker 
for conscientious care of the experimental  animals, and Helen Blahnik for excellent secretarial 
assistance. 
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